Evidence map›Paper›PMID 40893782›Full record

ArticleIBRO neuroscience reports2025

Systemic administration of gold nanoparticles attenuates anxiety-related behaviors and enhances spatial learning performance in rats.

Farideh Bahrami, Sajjad Rahimzadeh, Mahdi Mashhadi Akbar Boojar, Ahad Baqeri, Maryam Ghorbani, Mehdi Saberi

Abstract read
In one paragraph

Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Farideh BahramiNeuroscience Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Sajjad RahimzadehDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mahdi Mashhadi Akbar BoojarDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Ahad BaqeriDepartment of Physics, Faculty of Physics and Chemistry, AlZahra University, Tehran, Iran.
Maryam GhorbaniDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mehdi SaberiDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Due to the unique characteristics of gold nanoparticles, including low toxicity, tissue compatibility, high surface-to-volume ratio, excellent stability, lack of immunogenicity, and the ability to cross the blood-brain barrier, gold nanoparticles can affect brain cells and impact neuronal functions. This study aimed to investigate the effect of gold nanoparticles (AuNPs) on rats' anxiety, memory, and learning ability. Method: This study was conducted on 35 male Wistar rats that were obtained from the Animal Center of Baqiyatallah University. In order to measure the anxiety level of rats, an open field test and elevated maze were used. To measure the spatial learning of rats, the Barnes maze test was used. Also, to measure active avoidance behavior, the shuttle box was used. Data analysis was done using one-way ANOVA and P < 0.05 was considered significant. Results: The results of the study showed that gold nanoparticles with doses of 200 and 300 μg/ml had a significant effect on memory and learning, which was observed both in the Barnes maze and the shuttle box test. Also, gold nanoparticles with a dose of 100 μg/ml reduced the induced anxiety of the animal, which had a significant difference with the control group (P < 0.05). Conclusion: The study revealed that gold nanoparticles can impact rats' anxiety, memory, and learning. This suggests gold nanoparticles could be a new therapy to help with anxiety and cognitive issues in rodents, with potential benefits for humans.

Indexed as

AnxietyGold nanoparticlesLearningMemory

Identifiers

PMID40893782
PMCPMC12392763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.